Xiamen Mayah Pharma Co., Ltd.
Other

地址:Room 301, Building A, Sanfu Fortune Center, No. 990-992, Anling Road, Huli Dist., Xiamen, China China (Mainland) Xiamen Fujian

主营产品:

主要市场:North America South America Southeast Asia Mid East Western Europe

业务范围:Vinpocetine, Entecavir Mono, Ambrisentan, Bosentan Mono, Conivaptan HCl, Milnacipran HCl, Levomilnacipran HCl, Ramelteon, and Intermediates for those products, RitonavirLopinavir intermediates

注册资本: 3000000

公司规模:11 - 50People

成立年份:2008

法人代表:X.M.Shao

X.M.Shao

+86-592-216017315395920831

sales@mayahpharm.com

www.mayahpharm.com

Mayah Pharma has been established on the basis of chemical science and technology, Who is an integrative company combined with R&D, Manufacturing and contract manufacturing business. We, Mayah Pharma takes most importance on cultivating and strengthening the ability of innovation, fully respecting the benefits of customers, meeting the requirements from the customers. Based on the needs of market and customers, we established a strong and high-efficiency team who owns much experience on R&D, Manufacturing and marketing; Be provided with the strong capability of independency research and innovation, and supply of high quality products; Coming into being our own special products series: Anti-Cancer, Anti-Virus, Anti-Fungal, Cardiovascular, Anti-Parkinson and Antidepressant and their related intermediates, and moreover, we could supply high purity of Chiral Reagents.
Mayah Pharma is equipped with modern R&D centre and first-class manufacturing base, we can provide the excellent products from grams to metric tons, insisting on the idea of “Customer First”, dedicating in satisfying and more exceeding the customer’s expection, and being purposed on win-win, to make Mayah Pharma as a leading manufacturing and supplied in the field of Pharmaceutical and Chemical in China.